Value through Innovation27 July 2016

Clinical Study Results

  • Mucosolvan ® - Healthy
    Clinical Study Number 18.509
    Study Indication Healthy
    Product Mucosolvan ®
    Generic Name Ambroxol
    Lab Code
    Clinical Phase I
    Study Title

    Relative bioavailability study between two formulations containing ambroxol hydrochloride, with administration under fasting condition in healthy volunteers of both sexes: soft pastilles test formulation of ambroxol hydrochloride 15 mg, manufactured by Bolder Arzneimittel GmbH & Co. KG and syrup reference formulation of ambroxol hydrochloride 6 mg/mL (Mucosolvan® adult syrup), manufactured by Boehringer Ingelheim Brasil Química e Farmaceutica Ltda.

    Study Document Trial synopsis 18.509 english

Clinical Trial Registry and structured study results. Find here protocol information for all clinical study types.

European Trial Register of EU studies.